Live Chat

Washington Post Exposes FDA’s Questionable Decisions Regarding Praxada

The Washington Post published an article recently reporting concerns that the FDA did not adequately review the safety and risks of the Pradaxa blood thinner. Reports of Pradaxa injuries are coming in daily to our office, including an Indiana man who has been taking Pradaxa since 2013, and now has blood in his urine, a Vermont woman who took Pradaxa since 2011 and now has internal bleeding, and a Michigan woman who took Pradaxa since 2014 and developed uncontrolled internal bleeding less than a year later. The Post’s article explained how the Project on Government Oversight (POGO) is investigating to determine if the warnings provided to patients were adequate. The article concluded that two members of the FDA advisory committee that made decisions regarding FDA approval of Pradaxa are partnered financially with Boehringer Ingelheim, Pradaxa’s manufacturer.
Legal Commentary
Fears Nachawati’s Pradaxa attorneys are studying, examining and investigating Pradaxa claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at
Drug Litigation